Pars plana vitrectomy with tissue plasminogen activator for traumatic submacular hemorrhage
Author:
Corresponding Author:

Rajendra S. Apte. Campus box 8096, 660 South Euclid Avenue, St. Louis, MO 63110, USA. apte@wustl.edu

Affiliation:

Clc Number:

Fund Project:

Supportea by DeNardo Education and Research Foundation Grant; Jeffrey T. Fort Innovation Fund; Siteman Retina Research Fund; Research to Prevent Blindness Inc. Getahun H is supported by Washington University in St. Louis School of Medicine Dean’s Medical Student Research Fellowship for the MD5 Yearlong Research Program. Getahun H is also a recipient of a Research to Prevent Blindness Medical Student Eye Research Fellowship.

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    AIM: To evaluate visual outcomes of pars plana vitrectomy (PPV) combined with tissue plasminogen activator (tPA)-induced clot lysis and pneumatic displacement for submacular hemorrhage (SMH) in a cohort of closed-globe trauma patients. METHODS: A retrospective, multicenter interventional case series involving 7 eyes of 7 patients who underwent PPV with subretinal tPA administration for SMH secondary to closed-globe injury were conducted. The primary outcome measure was the change in Snellen visual acuity. RESULTS: The mean age of patients was 32y (range: 21-51y), with a mean follow-up duration of 4.6mo (range: 1.1-14.9mo). The average best-corrected visual acuity (BCVA) was 20/1020 at baseline and 20/114 at the final visit, respectively (P=0.025). Preoperative BCVA was not a significant predictor of final BCVA (r=0.102, P=0.827). Final BCVA did not differ significantly between patients who underwent PPV within 14d of symptom onset and those who underwent surgery after 14d (P=0.57). All eyes received SF6 or C3F8 gas tamponade. CONCLUSION: Surgical intervention involving tPA-mediated clot lysis and pneumatic displacement may yield visual benefits in trauma-induced SMH without underlying retinal vascular disease; however, larger prospective studies are warranted to confirm these findings.

    Reference
    Related
    Cited by
Get Citation

Wilson X. Wang, Kishan G. Patel, Henok Getahun, et al. Pars plana vitrectomy with tissue plasminogen activator for traumatic submacular hemorrhage. Int J Ophthalmol, 2025,18(9):1797-1802

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:March 19,2025
  • Revised:May 02,2025
  • Adopted:
  • Online: August 18,2025
  • Published: